Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.88
Delayed Data
As of 4:00pm ET
 +0.08 / +2.86%
Today’s Change
1.93
Today|||52-Week Range
3.55
+35.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues66.5M45.4M143.8M62.7M
 
 
 
 
 
Cost of Goods Sold4.1M2.6M4.5M5.6M
 
 
 
 
 
Depreciation And Amortization6.0M6.0M6.1M--
 
 
 
 
 
Operating ExpensesGross Income56.4M36.9M133.2M57.2M
 
 
 
 
 
General Expenses15.0M16.9M19.2M17.6M
 
 
 
 
 
Other Operating Expenses0.000.000.006.3M
 
 
Research And Development1.9M1.8M4.3M605.0K
 
 
 
 
 
Total Operating Expenses25.1M25.5M29.8M29.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income41.4M19.9M114.0M33.3M
 
 
 
 
 
Extraordinary Credit5.8M0.00----
 
 
Extraordinary Charge-57.2M-1.4M-1.2M-700.0K
 
 
 
 
 
Interest Expense On Debt4.7M5.0M5.0M5.1M
 
 
 
 
 
Other Expenses184.0K212.0K6.5M-2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M13.7M114.3M25.5M
 
 
 
 
 
Income Taxes-4.3M-6.6M-53.9M-4.8M
 
 
 
 
 
Minority Interest-56.0K-47.0K0.000.00
 
 
 
Net Income-10.3M7.2M60.4M20.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS164.0M163.7M155.7M151.1M
 
 
 
 
 
Shares To Calculate EPS Diluted164.5M164.0M156.4M152.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06$0.04$0.39$0.14
 
 
 
 
 
EPS Diluted-$0.06$0.04$0.39$0.14